Prolactin in multiple sclerosis

Multiple Sclerosis Journal

Volumn 19, Issue 1, 2013, Pages 15-23

  Zhornitsky, Simon ^a,b   Yong, V Wee ^a,b   Weiss, Samuel ^b   Metz, Luanne M ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Hyperprolactinemia; multiple sclerosis; myelin; optic neuritis; pregnancy; prolactin; remyelination

Indexed keywords

BETA INTERFERON; BROMOCRIPTINE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLOSPORIN; DEXAMETHASONE; DOPA; GONADORELIN; METHYLPREDNISOLONE; METOCLOPRAMIDE; PROLACTIN; PROTIRELIN; SULPIRIDE;

CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; HYPERPROLACTINEMIA; HYPOTHALAMUS DISEASE; LONGITUDINAL STUDY; MULTIPLE SCLEROSIS; OPTIC NEURITIS; RELAPSE; REMISSION; REVIEW; SYSTEMATIC REVIEW;

EID: 84872325753     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512458555     Document Type: Review

References (49)

1. Cohen JA, Rudick RA 3 rd ed. City: Informahealthcare, 2007, London, UK. London, UK: Informahealthcare ; 2007 :
2. Beck CA, Metz LM, Svenson LW, Patten SB. Regional variation of multiple sclerosis prevalence in Canada. Mult Scler. 2005 ; 11: 516-519
3. Gregg C. Pregnancy, prolactin and white matter regeneration. J Neurol Sci. 2009 ; 285: 22-27
4. Vukusic S, Hutchinson M, Hours M, et al. Pregnancy and multiple sclerosis (the PRIMS study): Clinical predictors of postpartum relapse. Brain. 2004 ; 127: 1353-1360
5. Langer-Gould A, Huang SM, Gupta R, et al. Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch Neurol. 2009 ; 66: 958-963
6. Hellwig K, Rockhoff M, Gold R, et al. Exclusive breastfeeding is beneficial in postpartum relapse rate reduction: A prospective study of 72 MS patients. Mult Scler. 2011 ; 17: S277 - S505
7. Portaccio E, Ghezzi A, Hakiki B, et al. Breastfeeding is not related to postpartum relapses in multiple sclerosis. Neurol. 2011 ; 77: 145-150
8. Matera L, Rapaport R Neuroimmune biology vol 2. Growth and lactogenic hormones. 2. Growth and lactogenic hormones. 1st ed. New York: Elsevier, 2002. New York: Elsevier ; 2002 :
9. Freeman ME, Kanyicska B, Lerant A, et al. Prolactin: Structure, function, and regulation of secretion. Physiol Rev. 2000 ; 80: 1523-1631
10. Gregg C, Shikar V, Larsen P, et al. White matter plasticity and enhanced remyelination in the maternal CNS. J Neurosci. 2007 ; 21: 1812-1823
11. Yong VW. Prospects of repair in multiple sclerosis. J Neurol Sci. 2009 ; 277: S16 - S18
12. Chikanza IC. Prolactin and neuroimmunomodulation: In vitro and in vivo observations. Ann N Y Acad Sci. 1999 ; 876: 119-130
13. Horseman ND, Zhao W, Montecino-Rodriguez E, et al. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 1997 ; 16: 6926-6935
14. Bouchard B, Ormandy CJ, Di Santo JP, et al. Immune system development and function in prolactin receptor-deficient mice. J Immunol. 1999 ; 163: 576-582
15. Mangurian LP, Walsh RJ, Posner BI. Magnesium-dependent non-specific binding of [125I]prolactin to myelinated tracts in the rat central nervous system. Biochem Biophys Res Commun. 1989 ; 158: 986-990
16. Johnson T, Mowbray H, Verhaeghe B, et al. Assessing the safety and efficacy of prolactin in EAE: A step towards a clinical trial of prolactin in multiple sclerosis. Mult Scler. 2009 ; 15: S151 - S269
17. Riskind PN, Massacesi L, Doolittle TH, et al. The role of prolactin in autoimmune demyelination: Suppression of experimental allergic encephalomyelitis by bromocriptine. Ann Neurol. 1991 ; 29: 542-547
18. Canonico PL, Sortino MA, Favit A, et al. Dihydroergocryptine protects from acute experimental allergic encephalomyelitis in the rat. Funct Neurol. 1993 ; 8: 183-188
19. Esquifino AI, Cano P, Zapata A, et al. Experimental allergic encephalomyelitis in pituitary-grafted Lewis rats. J Neuroinflamm. 2006 ; 3: 20
20. Esquifino AI, Cano P, Jimenez V, et al. Experimental allergic encephalomyelitis in male Lewis rats subjected to calorie restriction. J Physiol Biochem. 2004 ; 60: 245-252
21. Matsiota P, Blancher A, Doyon B, et al. Comparative study of natural autoantibodies in the serum and cerebrospinal fluid of normal individuals and patients with multiple sclerosis and other neurological diseases. Ann Inst Pasteur Immunol. 1988 ; 139: 99-108
22. Grinsted L, Heltberg A, Hagen C, et al. Serum sex hormone and gonadotropin concentrations in premenopausal women with multiple sclerosis. J Intern Med. 1989 ; 226: 241-244
23. Awerbuch AI, Sandyk R. Prolactin secretion in multiple sclerosis. Int J Neurosci. 1991 ; 61: 145-148
24. Sandyk R, Awerbuch GI. Relationship of nocturnal melatonin levels to duration and course of multiple sclerosis. Int J Neurosci. 1994 ; 75: 229-237
25. Safarinejad MR. Evaluation of endocrine profile, hypothalamic-pituitary- testis axis and semen quality in multiple sclerosis. J Neuroendocrinol. 2008 ; 20: 1368-1375
26. Moshirzadeh S, Ghareghozli K, Harandi AA, et al. Serum prolactin level in patients with Relapsing-Remitting Multiple Sclerosis during relapse. J Clin Neurosci. 2012 ; 19: 622-623
27. Shafa MA, Vakilian A, Poorebrahimi A, et al. Serum prolactin level in multiple sclerosis patients. JRMS. 2006: 11 325-328
28. Nabavi SM, Koupai SA, Nejati MR, et al. Menstrual irregularities and related plasma hormone levels in multiple sclerosis patients treated with beta interferon. Acta Medica Iranica. 2009 ; 48: 36-41
29. Harirchian MH, Sahraian MA, et al. Serum prolactin level in patients with multiple sclerosis: A case control study. Med Sci Monit. 2006 ; 12: 177-180
30. Yamasaki K, Horiuchi I, Minohara M, et al. Hyperprolactinemia in optico-spinal multiple sclerosis. Intern Med. 2000 ; 39: 296-299
31. Orbach H, Zandman-Goddard G, Amital H, et al. Novel biomarkers in autoimmune diseases: Prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann NY Acad Sci. 2007 ; 1109: 385-400
32. Da Costa R, Szyper-Kravitz M, Szekanecz Z, et al. Ferritin and prolactin levels in multiple sclerosis. Isr Med Assoc J. 2011 ; 13: 91-95
33. Markianos M, Koutsis G, Evangelopoulos ME, et al. Serum and cerebrospinal fluid prolactin levels in male and female patients with clinically-isolated syndrome or Relapsing-Remitting Multiple Sclerosis. J Neuroendocrinol. 2010 ; 22: 503-508
34. Azar ST, Yamout B. Prolactin secretion is increased in patients with multiple sclerosis. Endocr Res. 1999 ; 25: 207-214
35. Kira J, Harada M, Yamaguchi Y, et al. Hyperprolactinemia in multiple sclerosis. J Neurol Sci. 1991 ; 102: 61-66
36. Wei T, Lightman SL. The neuroendocrine axis in patients with multiple sclerosis. Brain. 1997 ; 120: 1067-1076
37. Neeck G, Federlin K, Graef V, et al. Adrenal secretion of cortisol in patients with rheumatoid arthritis. J Rheumatol. 1990 ; 17: 24-29
38. Heesen C, Schulz H, Schmidt M, et al. Endocrine and cytokine responses to acute psychological stress in multiple sclerosis. Brain Behav Immun. 2002 ; 16: 282-287
39. Heesen C, Gold SM, Bruhn M, et al. Prolactin stimulation in multiple sclerosis - An indicator of disease subtypes and activity?. Endocr Res. 2002 ; 28: 9-18
40. Lombardi G, Celso M, Bartelli M, et al. Female sexual dysfunction and hormonal status in multiple sclerosis patients. J Sex Med. 2011 ; 8: 1138-1146
41. Then Bergh F, Kumpfel T, Schumann E, et al. Monthly intravenous methylprednisolone in Relapsing-Remitting Multiple Sclerosis - Reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurol. 2006 ; 6: 19
42. Then Bergh F, Kumpfel T, Yassouridis A, et al. Acute and chronic neuroendocrine effects of interferon-beta 1a in multiple sclerosis. Clin Endocrinol. 2007 ; 66: 295-303
43. Goebel MU, Baase J, Pithan V, et al. Acute interferon beta-1b administration alters hypothalamic-pituitary-adrenal axis activity, plasma cytokines and leukocyte distribution in healthy subjects. Psychoneuroendocrinol. 2002 ; 27: 881-892
44. Reder AT, Lowy MT. Serum prolactin levels in active multiple sclerosis and during cyclosporin treatment. J Neurol Sci. 1993 ; 117: 192-196
45. Bissay V, De Klippel N, Herroelen L, et al. Bromocriptine therapy in multiple sclerosis: An open label pilot study. Clin Neuropharmacol. 1994 ; 17: 473-476
46. McMurray RW, Allen SH, Braun AL, et al. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: Possible hormonal stimulation of an autoimmune disease. J Rheumatol. 1994 ; 21: 843-850
47. Lennartsson AK, Jonsdottir IH. Prolactin in response to acute psychosocial stress in healthy men and women. Psychoneuroendocrinol. 2011 ; 36: 1530-1539
48. Sobrinho LG. Prolactin, psychological stress and environment in humans: Adaptation and maladaptation. Pituitary. 2003 ; 6: 35-39
49. Huitinga I, Erkut ZA, Van Beurden D, et al. Impaired hypothalamus- pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions. Ann Neurol. 2004 ; 55: 37-45